Parts of a whole analysis visualizing the relative distribution of <i>T. colubriformis</i> L3 in each height zone. by Katy A. Martin (9216905)

Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

“…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”

Professional development participation is not associated with a decrease in total publication. by Patrick D. Brandt (4449211)

VANGL2 interacts with NLRP3. by Huaji Jiang (16907514)

Phenotypic analyses of miR-125b expressing granulocytes after thioglycollate injection. by Chun-Wei Lee (321042)

Untransformed polyclonal IL23R^Q381 positive T cell have decreased IL-23 induced pSTAT1 and pSTAT5 compared to IL23R^R381 T cell lines. by Svetlana Pidasheva (201304)

Visualization of all motifs that include mir-139-5p and its interactions with central-hubs. by Mohammad R. Irhimeh (614626)

Subjects:

Ultrastructural defects of the epithelium in <i>Slc9a3</i>^{<i>–/–</i>}epididymis and vas deferens. by Ya-Yun Wang (175049)

“…(A, B) Caput epididymis. The arrow indicates the absence of stereocilia on the caput epithelium. …”

Analysis of the ¹ H–¹⁵N HSQC spectrum of the RAGE V domain with unlabeled S100A1. by Md. Imran Khan (4853302)

“…Cross-peaks displaying significantly decreased intensity are shown in green boxes.</p> <p>(B) Bar graph analysis representing the intensity change (I/I₀) of cross-peaks of ¹⁵N V domain to ¹⁵N V domain complex with S100A1 versus residue numbers of RAGE V domain (24–128). …”

DataSheet_1_PACAP–PAC1 Signaling Regulates Serotonin 2A Receptor Internalization.pdf by Atsuko Hayata-Takano (525514)

“…In addition, the levels of endogenous 5-HT_2A were decreased on the cell surface of primary cultured cortical neurons after PACAP stimulation and were increased in frontal cortex cell membranes of Pacap^−/− mice. …”

DDX5 and DDX17 recruit Brg1 to the RTA and ZTA promoters, and Brg1 is important for gammaherpesviral lytic reactivation. by Praneet Kaur Sandhu (21156149)

Inhibition of PI3-Kinase alters choline uptake in SH-SY5Y cells. by Katherine J. Fishwick (768451)

Protection efficacy of XBB-BA.5 RBD-dimer vaccine. by Tongxin Zhao (19513228)

Analysis of the ¹H–¹⁵N HSQC spectrum of the labeled RAGE V domain with unlabeled S100A12. by Jian Wei Chiou (3106578)

“…<p>(a) Overlay of the ¹H–¹⁵N HSQC spectra of 0.5 mM ¹⁵N-labeled RAGE V domain (red) and the spectra of the complex with 0.5 mM unlabeled S100A12 (blue). …”

CRH induces a decrease in macrophage ABCA1 expression. by Wonkyoung Cho (760305)

RAC1 inhibition results in a decrease in oxidative phosphorylation. by Shruthi Sriramkumar (12705564)

Position of viscous fingering at 0.5s. by Yu-Ting Wu (2057263)

(A) Maximum percent decrease in FEV for each patient from postdose/pre-challenge after treatment with placebo (DB-placebo) or levalbuterol (DB-levalbuterol) during the double-blind... by D.S. Pearlman (92703)

Analysis of the ¹H–¹⁵N HSQC spectra of S100A12 in complex with the unlabeled RAGE V domain. by Jian Wei Chiou (3106578)

“…<p>(a) Overlay of the ¹H–¹⁵N HSQC spectra of 0.76 mM ¹⁵N-labeled S100A12 (red) and S100A12 in complex with 0.76 mM unlabeled RAGE V domain (green). …”

DPOAE responses are decreased one week after treatment with 8,000 mg/kg HPβCD. by Mark A. Crumling (107429)